ScienceMachine

The company provides an AI agent platform designed to automate end-to-end biomedical research workflows, including mass spectrometry processing, flow cytometry analysis, and report generation. The software integrates with existing data sources and tools to perform result interpretation based on referenced literature and data visualization. Its target market consists of life sciences companies and research teams requiring reproducible computational biology and machine learning automation.